0       0


MN3-31: Current Update on Next Generation Blood Products for Treatment of Mass Casualty, Military or Pre-hospital Trauma Resuscitation


Oct 21, 2019 2:00pm ‐ Oct 21, 2019 3:30pm

Description

Mass causality events, civilian-based terrorism, and traumatic injury on the military battlefield have highlighted the shortcomings of traditional blood product storage and use within these challenging front line environments. Preparedness and prevention of death from hemorrhage requires the availability and placement of new and innovative blood products with first responders (civilian EMS, military medics, and rural or isolated emergency rooms). This work shop will provide an update on the status of investigational blood products which are designed to meet this front line need (and which are the most advanced in clinical development): freeze dried plasma, spray dried plasma and freeze dried platelets. 

Learning Objectives:

  • Classify next generation blood products, their indications, clinical safety and efficacy results, and their associated development timelines.
  • Differentiate the advantages of next generation blood products from current traditional blood products, including improved time to initiation of transfusion and inventory management.
  • Evaluate the inclusion of next generation blood products into modernized first responder protocols.

**Please note that this education session will not offer CME. You will be able to claim CE for the session.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content